Question 1

Isn't bipolar disorder just having mood swings?

Accepted Answer

No, and this is the misconception the word itself created. In everyday speech 'bipolar' has come to mean changeable, unpredictable or self-contradictory — someone whose mood shifts through the day, or who reacts strongly. That is not what the diagnosis describes. Bipolar disorder is defined by sustained episodes, measured in days and weeks rather than hours: mania lasts at least a week or is severe enough to need hospital care; hypomania lasts at least four days and is an observable change from how that person normally is, not simply a good mood or a productive spell. Between episodes many people are well. Ordinary mood variability — feeling up on Tuesday and flat on Wednesday, or being upset by something upsetting — is not this condition, and describing it that way makes a serious illness sound like a personality trait. It also cuts the other way: because people picture dramatic hourly swings, they do not recognise the real thing, which usually looks like depression with a history of episodes that nobody asked about.

Question 2

Is bipolar II just a milder version of bipolar I?

Accepted Answer

No, and the data are fairly clear on this. The difference between the two is the type of high, not the overall severity: bipolar I involves at least one full manic episode, while bipolar II involves hypomania — a shorter, less extreme high that does not cause the same degree of disruption or require hospital care — together with depression. It is easy to read that as 'bipolar I with the volume turned down'. But in the large international epidemiological data, while symptom severity does increase step by step from subthreshold conditions up to bipolar I, role impairment — the effect on someone's ability to work and function — was similar across the bipolar subtypes. The reason is the depression. In bipolar II the depressive episodes are frequently more prolonged, and depressive symptoms carry greater severity than manic ones overall. So a person with bipolar II is not a person with a lighter illness. They have a different pattern, in which the part that causes most of the harm is the part that is not in the name.

Question 3

How is bipolar depression different from ordinary depression?

Accepted Answer

During the episode itself, often not obviously — which is precisely the problem. Bipolar depression and unipolar depression can look and feel the same, and the difference lies in the history rather than the presentation: whether there has ever been a period of elevated or irritable mood with increased energy and reduced need for sleep. This matters more than a technicality, because the treatments diverge. Some features raise suspicion — depression starting young, episodes that are frequent or come with psychotic features, depression that has not responded to several antidepressants, or a strong family history — but none is decisive on its own. The practical reason it gets missed is human rather than medical: people seek help when they are depressed, not when they are hypomanic, because hypomania does not feel like an illness. It can feel like energy, confidence, and finally getting things done. If nobody asks about it, it does not come up. If you have been treated for depression and any of that sounds familiar, it is worth raising specifically.

Question 4

Should I avoid antidepressants if I have bipolar disorder?

Accepted Answer

Not necessarily — and both confident answers to this question are wrong. The concern is real: an antidepressant given ALONE, without a mood stabiliser, can in some people precipitate mania, hypomania or a mixed state, and antidepressant monotherapy is not a recommended treatment for bipolar depression. That is the basis of the warning, and it is a good warning. But it has often been stretched into 'antidepressants are forbidden in bipolar disorder', which the evidence does not support. In the largest randomised trial of the question, adding a standard antidepressant to a mood stabiliser produced durable recovery in 23.5% of people, compared with 27.3% on a mood stabiliser plus placebo — no benefit, but also no significant difference, and notably the rates of switching into mania were similar in both groups. So the honest reading is nuanced in both directions: adjunctive antidepressants did not help, and they also did not cause the switch that everyone fears, at least when a mood stabiliser was on board. Expert guidance reflects this — antidepressants have a limited, specific place, are not first-line, should not be used alone, and are avoided in mixed states and rapid cycling. This is a decision to make with a psychiatrist, not a rule to apply from a page.

Question 5

Is lithium worth it, given the side effects?

Accepted Answer

For many people, yes — and the folklore about lithium is meaningfully worse than the evidence. It remains the best-established long-term treatment for preventing episodes, and it is the drug most closely associated with reduced suicide risk in mood disorders, though that specific claim deserves precision (see below). The monitoring is real: lithium has a narrow therapeutic range, needs periodic blood levels, and a systematic review found it associated with reduced urinary concentrating ability, hypothyroidism, hyperparathyroidism and weight gain. But the same review found little evidence of clinically significant loss of kidney function in most patients, and that the risk of end-stage renal failure is low — which is not what the 'lithium destroys your kidneys' story implies. Thyroid and parathyroid effects are monitorable and treatable. Dehydration, NSAIDs and some blood pressure drugs raise lithium levels, which is why toxicity is usually a situation rather than an inevitability. Two things to know: stopping lithium abruptly is associated with a high risk of relapse, so it is not a drug to stop on impulse; and in pregnancy the malformation risk is uncertain and the review's own advice was that the balance of risks should be weighed before withdrawing it, not that withdrawal is automatic.

Question 6

Does lithium prevent suicide?

Accepted Answer

This is more contested than you will usually be told, and BioSignal will give you the actual state of it rather than the headline. The widely cited position comes from a 2013 meta-analysis which concluded that lithium is effective in reducing suicide risk in people with mood disorders, and it is genuinely influential. But a later meta-analysis restricted to randomised trials reached a different conclusion: across 12 studies and 2,578 participants, suicide occurred in 0.2% of those randomised to lithium versus 0.4% on placebo or usual treatment — an odds ratio of 0.41, but with a confidence interval from 0.03 to 2.49 and no statistical significance. Its authors concluded the randomised evidence is inconclusive. The crucial thing is what that does and does not mean. It is not a finding that lithium fails to prevent suicide. Suicide is rare, the trials were small, and a confidence interval that wide is the signature of a study that cannot answer the question — a subsequent analysis argued exactly this, attributing the non-significance to insufficient power and noting that the direction of effect aligns with the observational evidence. So: the observational data support an antisuicidal effect, the point estimates favour lithium, the randomised evidence is too imprecise to confirm it, and 'not statistically significant' is not the same as 'no effect'. Lithium remains a leading treatment; the suicide claim specifically is probable rather than proven.

Question 7

Will supplements, ketamine or psychedelics help?

Accepted Answer

BioSignal is not going to overpromise here, because this is an area where hope is being sold ahead of evidence. On supplements: none is an established treatment for bipolar disorder, and none should replace a mood stabiliser. On ketamine and psychedelics: there is genuine research interest in mood disorders, but the evidence base in bipolar disorder specifically is much thinner than the public conversation implies, and bipolar disorder is frequently an exclusion criterion in the very trials whose results are being generalised to it. There is also a specific and non-theoretical concern: agents that acutely elevate mood carry a risk of precipitating mania or psychosis in someone with a bipolar diathesis, which is precisely the population being encouraged to try them by people who have not read the exclusion criteria. What does have evidence, and gets less attention, is unglamorous: mood stabilisers, structured psychological therapy, psychoeducation, protecting sleep and routine, and treating substance use. If you want to try something new, the safe route is a trial or a psychiatrist — not a purchase.

Question 8

When does bipolar disorder need urgent help?

Accepted Answer

When safety is at stake, and there are several distinct forms of that. Thoughts of suicide or self-harm need urgent help now — suicide risk in bipolar disorder is real and substantial, and it is not something to sit with alone or to research. Mania with dangerous behaviour — spending or risk-taking with serious consequences, driving recklessly, not sleeping for days, believing things that are not true — needs urgent psychiatric assessment, and often the person experiencing it is the last to see the problem, which is why an agreed plan with someone you trust matters so much. Psychosis, whether hallucinations or fixed false beliefs, needs assessment. So does being unable to care for yourself — not eating, not drinking, not sleeping. If you are supporting someone in this position and they will not seek help, contact their mental health team, an urgent care service or emergency services; this is one of the situations where acting on someone's behalf is appropriate. Most of the time, bipolar disorder is a condition managed in ordinary life. These specific situations are not that, and a page is not what they need.

Bipolar Disorder

What it is

Why it matters

What BioSignal knows about treating this

What works for Bipolar Disorder

Signal Records relevant to this condition

New to this? Read these first

How this usually unfolds

Who is at risk

How it's diagnosed

Key biomarkers

Lifestyle

Explore this condition across BioSignal

Related Foundations

Related Signal Records

Related body systems

Related conditions

Frequently asked questions